Birchbrook
MRNA icon

Birchbrook’s Moderna MRNA Stock Holding History

Birchbrook’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$77K Hold
400
– – 0.04% 113
2026
Q2 		$28K Hold
400
– – 0.01% 155
2026
Q1 		$20.3K Hold
400
– – 0.01% 161
2025
Q4 		$11.8K Hold
400
– – 0.01% 197
2025
Q3 		$10.3K Hold
400
– – 0.01% 190
2025
Q2 		$11K Hold
400
– – 0.01% 188
2025
Q1 		$11.3K Hold
400
– – 0.01% 180
2024
Q4 		$16.6K Hold
400
– – 0.01% 177
2024
Q3 		$26.7K Sell
400
-200
-33% -$18.4K 0.01% 141
2024
Q2 		$71.2K Hold
600
– – 0.04% 106
2024
Q1 		$63.9K Hold
600
– – 0.04% 111
2023
Q4 		$59.7K Buy
+600
New +$50.5K 0.04% 111

Other funds holding MRNA

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Leonteq Securities AG
Leonteq Securities AG Zurich, Switzerland $2.44B AUM 50.17% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

Birchbrook's MRNA Position: Q3 2026 in Review

Birchbrook held its Moderna (MRNA) position steady in Q3 2026 at 400 shares worth $77K. The position accounts for 0.04% of the portfolio, ranked #113.

Birchbrook first reported a position in MRNA in Q4 2023 and has held it in 12 quarters since. 354 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Birchbrook held 400 shares of Moderna worth $77K as of Q3 2026.
  • Birchbrook left its Moderna share count unchanged in Q3 2026.
  • Moderna made up 0.04% of Birchbrook's portfolio in Q3 2026, its #113 holding.
  • Birchbrook first reported a position in Moderna in Q4 2023 and has held it in 12 quarters since.
  • 354 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Birchbrook's 13F filing for Q3 2026, filed 14 Oct 2026.